Augustine Therapeutics
PrivateLast Round
Series A
Mar 24, 2025
Total Funding Raised
$108.08M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Augustine Therapeutics is a biotechnology company that develops therapeutic drugs designed to treat neuromuscular and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Augustine Therapeutics Comparables
Compare Augustine Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regenacy Pharmaceuticals | 87% | |
| Eikonizo Therapeutics | 85% | |
| HDAX Therapeutics | 83% | |
Augustine Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 24, 2025 | ||||
| Series A | Jun 26, 2024 | ||||
| Seed | Feb 26, 2020 |
Augustine Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Newton Biocapital | Series A |
| KU Leuven Research & Development (LRD) | Seed, Series A |
| V-Bio Ventures | Series A, Seed |
| Novo Holdings | Series A |
| PMV | Seed, Series A |
| VIB | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 6, representing 25% of headcount.
- Jan 20, 2026
Monthly visitors grew 406% MoM, reaching 3.1K.
Augustine Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Augustine Therapeutics's valuation, stock price, and market status.